Cosmos Health (COSM) EBT Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly EBT Margin came in at 15.65% in Q1 2026, down 968.0% YoY from 1.8% in Q1 2025, and down 167.66% on a QoQ basis from 23.13% in Q4 2025.
Cosmos Health (COSM) EBT Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has 12 years of EBT Margin data on file, last reported at 15.65% in Q1 2026.
- Quarterly EBT Margin fell 968.0% year-over-year to 15.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 357.24% (down 32898.0% YoY) and the FY2025 annual result came in at 1126.18%, down 109644.0% from the prior year.
- EBT Margin slipped to 15.65% in Q1 2026, from 23.13% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 23.13% in Q4 2025 to a low of 87.28% in Q4 2022.
- A 5-year average of 26.27% and a median of 17.59% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin slumped 7845 bps — and 2025, when it soared 9022 bps.
- Tracing COSM's EBT Margin over 5 years: stood at 87.28% in 2022, then advanced by 1 bps to 86.82% in 2023, then climbed by 23 bps to 67.09% in 2024, then surged by 134 bps to 23.13% in 2025, then tumbled by 168 bps to 15.65% in 2026.
- The last three EBT Margin figures came in at 15.65% (Q1 2026), 23.13% (Q4 2025), and 31.28% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.24% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.18% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 0.87% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 3.96% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -109.10% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -14.29% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -1.14% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -32.06% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -5.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.65% |
| Dec 31, 2025 | 23.13% |
| Sep 30, 2025 | -31.28% |
| Jun 30, 2025 | -19.18% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -67.09% |
| Sep 30, 2024 | -17.59% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -12.80% |
| Dec 31, 2023 | -86.82% |
| Sep 30, 2023 | -26.63% |
| Jun 30, 2023 | -7.19% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | -87.28% |
| Sep 30, 2022 | -16.58% |
| Jun 30, 2022 | -9.33% |
| Mar 31, 2022 | -42.73% |
| Dec 31, 2021 | -8.82% |
| Sep 30, 2021 | -13.00% |
| Jun 30, 2021 | -14.57% |